https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Hepatology 2009 Jan;49(1):124-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Hepatology 2009 Jan;49(1):124-322009-01-01 00:00:002020-01-08 10:10:21A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-662009-01-01 00:00:002021-11-15 17:02:36Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-16 / Jpn. J. Clin. Oncol. 2009 Feb;39(2):73-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-16 / Jpn. J. Clin. Oncol. 2009 Feb;39(2):73-802008-11-16 00:00:002019-02-15 08:44:32Recent advances in cancer vaccines: an overview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-900
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-9002008-11-08 00:00:002021-11-15 17:03:25Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-132008-10-25 00:00:002019-02-15 08:44:25Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-672008-09-20 00:00:002019-02-15 08:45:28The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-19 / Immunity 2008 Sep;29(3):372-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-19 / Immunity 2008 Sep;29(3):372-832008-09-19 00:00:002019-02-15 08:44:33Cancer immunotherapy by dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-01 / J. Immunother. 2008 Sep;31(7):620-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-01 / J. Immunother. 2008 Sep;31(7):620-322008-09-01 00:00:002008-09-01 00:00:00Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-242008-08-12 00:00:002019-02-15 08:52:02Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-502008-08-01 00:00:002019-02-15 08:49:31Dendritic cell vaccines in metastasized malignant melanoma
